The Cost-effectiveness of Spinal Cord Stimulation in the Treatment of Failed Back Surgery Syndrome

Abstract

In selected patients with FBSS, SCS is cost effective both as an adjunct to CMM and as an alternative to reoperation. Despite their initial increased expense, rechargeable IPGs should be considered when IPG longevity is likely to be short.